Sign Up to like & get
recommendations!
0
Published in 2017 at "Neurology"
DOI: 10.1212/wnl.0000000000004102
Abstract: Soon after our article published,1 we learned the sale of the myxovirus resistance A (MxA) polyclonal antibodies used in the study (Mx1/2/3 [H-285], sc-50509, Santa Cruz Biotechnology, Dallas, TX) had been discontinued. Furthermore, we received…
read more here.
Keywords:
sarcoplasmic mxa;
mxa;
mxa expression;
dermatomyositis ... See more keywords